[Experimental study of T lymphocyte reactivity inhibited by allogeneic bone marrow mesenchymal stem cells]

Zhonghua Xue Ye Xue Za Zhi. 2005 Dec;26(12):740-2.
[Article in Chinese]

Abstract

Objective: To address the question whether bone marrow mesenchymal stem cells (MSCs) could lower responsiveness of allogeneic T lymphocytes against alloantigens, and explore a feasible strategy for prevention of graft versus host disease (GVHD) occurred in allogeneic bone marrow transplantation.

Methods: T cells were co-cultured with (60)Co-irradiated bone marrow MSCs from different individuals. The proliferative activity of T cells and their reactivity to allogeneic cells and ConA were evaluated with (3)H-TdR incorporation assay.

Results: T cells could not be activated upon primary or even secondary exposure to allogeneic MSCs (compared the CPM value of 27,529 +/- 969 of T cell alone with that of primary and secondary exposures to allogeneic MSCs were 9,126 +/- 654 and 13,260 +/- 874, respectively). When MSCs were induced to express HLA-DR, they still could not elicit T cell activation. The proliferation rate of allogenous T cells exposed to MSCs was dramatically declined when T cells from the same donor's MSCs were used as stimulator (CPM value decreased from 45,876 +/- 5285 before coculture to 9850 +/- 1618 after coculture). Furthermore, the results remained unchanged even ConA was added into the culture system.

Conclusions: Heterogenetic MSCs could suppress T cell activation. MSCs pretreatment might be useful in the prevention of GVHD in HLA-mismatched bone marrow transplantation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Marrow Cells / immunology*
  • Cell Communication / immunology
  • Cell Proliferation
  • Cells, Cultured
  • Coculture Techniques
  • Graft vs Host Disease / immunology
  • Graft vs Host Disease / prevention & control
  • Humans
  • Lymphocyte Activation
  • Mesenchymal Stem Cells / immunology*
  • T-Lymphocytes / immunology*